Dyne Therapeutics
The Director of Training leads Dyne’s training vision, strategy, and execution for field-facing teams, ensuring employees have the capabilities to achieve commercial excellence. This role provides strategic oversight of curriculum, learning systems, vendors, and cross-functional alignment to support onboarding, ongoing development, and product launches. The Director partners with Commercial, Medical, Compliance, Marketing, HR, and Field Leadership to translate business priorities into high-impact learning solutions and strengthen field readiness and leadership capabilities.
Headquarters
Waltham, Massachusetts, United States
Company Size
51-200 employees
Founded
2018
Dyne Therapeutics is a biotechnology company developing nucleic acid–based therapies for genetically driven neuromuscular diseases. Leveraging its proprietary FORCE™ platform, Dyne aims to address the root cause of disease and deliver functional improvement for people living with conditions such as Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and facioscapulohumeral muscular dystrophy (FSHD). The company advances a pipeline of therapeutics from discovery through clinical development with the mission of transforming the lives of patients with rare neuromuscular diseases.
Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)
2 days ago
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
3 days ago
Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8%
22 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dyne Therapeutics.
150-patient Dyne trial focuses on myotonic dystrophy daily function
3 days ago
Senior Manager, Training & Development, Obesity & Related Conditions - U.S. Remote
Amgen
Commercial Excellence Training Manager
Össur
Director of Training
8a7882525c3d7d8e015c8a384e6b377b
Fraternal Training Development Specialist
Modern Woodmen of America
Fraternal Training Development Specialist
Modern Woodmen of America
Associate Director, Commercial Training and Development
Amylyx Pharmaceuticals